Profile | GDS5420 / 212146_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 345.07 | 61 |
GSM1296119 | B_lesional_pre-dose | 47.16 | 28 |
GSM1296076 | C_lesional_pre-dose | 42.04 | 28 |
GSM1296092 | D_lesional_pre-dose | 160.61 | 51 |
GSM1296103 | E_lesional_pre-dose | 221.04 | 54 |
GSM1296078 | F_lesional_pre-dose | 98.21 | 42 |
GSM1296107 | G_lesional_pre-dose | 111.16 | 42 |
GSM1296109 | H_lesional_pre-dose | 228.55 | 53 |
GSM1296080 | I_lesional_pre-dose | 206.99 | 54 |
GSM1296090 | J_lesional_pre-dose | 126.27 | 46 |
GSM1296074 | K_lesional_pre-dose | 99.13 | 44 |
GSM1296111 | L_lesional_pre-dose | 115.32 | 42 |
GSM1296099 | M_lesional_pre-dose | 266.24 | 57 |
GSM1296086 | O_lesional_pre-dose | 146.54 | 49 |
GSM1296117 | P_lesional_pre-dose | 83.52 | 36 |
GSM1296113 | Q_lesional_pre-dose | 84.46 | 35 |
GSM1296096 | R_lesional_pre-dose | 241.15 | 56 |
GSM1296105 | S_lesional_pre-dose | 231.49 | 54 |
GSM1296098 | T_lesional_pre-dose | 334.84 | 61 |
GSM1296101 | U_lesional_pre-dose | 330.29 | 60 |
GSM1296121 | V_lesional_pre-dose | 86.59 | 38 |
GSM1296088 | W_lesional_pre-dose | 194.85 | 53 |
GSM1296082 | X_lesional_pre-dose | 135.77 | 48 |
GSM1296115 | Y_lesional_pre-dose | 141.47 | 46 |
GSM1296084 | Z_lesional_pre-dose | 179.73 | 51 |
GSM1296072 | B_lesional_day8 | 90.24 | 38 |
GSM1296069 | L_lesional_day8 | 113.88 | 40 |
GSM1296071 | P_lesional_day8 | 133.15 | 43 |
GSM1296070 | Y_lesional_day8 | 133.67 | 43 |
GSM1296073 | V_lesional_day8 | 83.17 | 38 |
GSM1296034 | A_lesional_day15 | 382.95 | 62 |
GSM1296041 | G_lesional_day15 | 103.84 | 41 |
GSM1296035 | R_lesional_day15 | 301.47 | 59 |
GSM1296038 | U_lesional_day15 | 252.91 | 56 |
GSM1296047 | B_lesional_day15 | 69.91 | 33 |
GSM1296039 | E_lesional_day15 | 120.59 | 45 |
GSM1296042 | H_lesional_day15 | 116.25 | 42 |
GSM1296043 | L_lesional_day15 | 114.48 | 41 |
GSM1296037 | M_lesional_day15 | 219.1 | 53 |
GSM1296046 | P_lesional_day15 | 93.44 | 37 |
GSM1296044 | Q_lesional_day15 | 89.33 | 37 |
GSM1296045 | Y_lesional_day15 | 110.66 | 40 |
GSM1296025 | C_lesional_day15 | 90.85 | 40 |
GSM1296033 | D_lesional_day15 | 153.24 | 48 |
GSM1296027 | I_lesional_day15 | 91.36 | 42 |
GSM1296032 | J_lesional_day15 | 89.15 | 40 |
GSM1296024 | K_lesional_day15 | 123.16 | 45 |
GSM1296031 | W_lesional_day15 | 179.03 | 50 |
GSM1296028 | X_lesional_day15 | 130.51 | 46 |
GSM1296029 | Z_lesional_day15 | 154.48 | 48 |
GSM1296026 | F_lesional_day15 | 109.82 | 43 |
GSM1296030 | O_lesional_day15 | 164.71 | 51 |
GSM1296040 | S_lesional_day15 | 364.56 | 62 |
GSM1296036 | T_lesional_day15 | 249.94 | 55 |
GSM1296048 | V_lesional_day15 | 82.29 | 37 |
GSM1296059 | A_lesional_day43 | 402.55 | 64 |
GSM1296066 | G_lesional_day43 | 116.18 | 42 |
GSM1296060 | R_lesional_day43 | 209.17 | 53 |
GSM1296063 | U_lesional_day43 | 157.02 | 48 |
GSM1296064 | E_lesional_day43 | 249.29 | 57 |
GSM1296067 | H_lesional_day43 | 138.58 | 44 |
GSM1296062 | M_lesional_day43 | 277.98 | 57 |
GSM1296068 | Q_lesional_day43 | 82.07 | 34 |
GSM1296050 | C_lesional_day43 | 50.44 | 30 |
GSM1296057 | D_lesional_day43 | 207.44 | 53 |
GSM1296052 | I_lesional_day43 | 135.46 | 48 |
GSM1296054 | J_lesional_day43 | 138.82 | 46 |
GSM1296049 | K_lesional_day43 | 126.31 | 45 |
GSM1296055 | W_lesional_day43 | 177.11 | 49 |
GSM1296053 | X_lesional_day43 | 137.3 | 46 |
GSM1296058 | Z_lesional_day43 | 297.68 | 59 |
GSM1296051 | F_lesional_day43 | 85.44 | 40 |
GSM1296056 | O_lesional_day43 | 249.44 | 57 |
GSM1296065 | S_lesional_day43 | 151.88 | 47 |
GSM1296061 | T_lesional_day43 | 341.98 | 61 |
GSM1296095 | A_non-lesional_pre-dose | 268.19 | 58 |
GSM1296120 | B_non-lesional_pre-dose | 69.51 | 33 |
GSM1296077 | C_non-lesional_pre-dose | 94.77 | 42 |
GSM1296093 | D_non-lesional_pre-dose | 218.83 | 53 |
GSM1296104 | E_non-lesional_pre-dose | 137.93 | 46 |
GSM1296079 | F_non-lesional_pre-dose | 87.38 | 40 |
GSM1296108 | G_non-lesional_pre-dose | 118.44 | 43 |
GSM1296110 | H_non-lesional_pre-dose | 138.01 | 44 |
GSM1296081 | I_non-lesional_pre-dose | 172.01 | 51 |
GSM1296091 | J_non-lesional_pre-dose | 142.94 | 48 |
GSM1296075 | K_non-lesional_pre-dose | 61.49 | 35 |
GSM1296112 | L_non-lesional_pre-dose | 150.38 | 45 |
GSM1296100 | M_non-lesional_pre-dose | 242.38 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 99.84 | 44 |
GSM1296118 | P_non-lesional_pre-dose | 82.09 | 35 |
GSM1296114 | Q_non-lesional_pre-dose | 103.65 | 39 |
GSM1296097 | R_non-lesional_pre-dose | 185.07 | 51 |
GSM1296106 | S_non-lesional_pre-dose | 178.82 | 49 |
GSM1296102 | U_non-lesional_pre-dose | 221.61 | 53 |
GSM1296122 | V_non-lesional_pre-dose | 83.9 | 36 |
GSM1296089 | W_non-lesional_pre-dose | 131.76 | 45 |
GSM1296083 | X_non-lesional_pre-dose | 210.42 | 53 |
GSM1296116 | Y_non-lesional_pre-dose | 95.19 | 37 |
GSM1296085 | Z_non-lesional_pre-dose | 124.54 | 45 |